BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3342719)

  • 1. Plasma CCK levels in patients with pancreatic insufficiency.
    Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
    Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum pancreatic polypeptide estimations following hormonal stimulation for the diagnosis of exocrine pancreatic insufficiency.
    Cichy W; Lankisch PG; Arnold R; Creutzfeldt W
    Digestion; 1984; 30(4):218-23. PubMed ID: 6510573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
    Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
    Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis.
    Herzig KH; Domagk J; Nustede R; Stern M; Bewig B; Cichy WK; Fölsch UR
    Scand J Gastroenterol; 1997 Apr; 32(4):315-9. PubMed ID: 9140152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
    Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
    Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation.
    Slaff JI; Wolfe MM; Toskes PP
    J Lab Clin Med; 1985 Mar; 105(3):282-5. PubMed ID: 3973464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.
    Jansen JB; Hopman WP; Lamers CB
    Dig Dis Sci; 1984 Dec; 29(12):1109-17. PubMed ID: 6499629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels.
    Beglinger C; Fried M; Whitehouse I; Jansen JB; Lamers CB; Gyr K
    J Clin Invest; 1985 May; 75(5):1471-6. PubMed ID: 3998145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pancreatic polypeptide on the pancreatic exocrine secretion stimulated by secretin and cholecystokinin in the conscious pig.
    Langlois A; Corring T; Cuber JC; Gueugneau AM; Levenez F; Chayvialle JA
    Regul Pept; 1989 Jan; 24(1):55-65. PubMed ID: 2740529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency.
    Jansen JB; Jebbink MC; Mulders HJ; Lamers CB
    Regul Pept; 1989; 25(3):333-42. PubMed ID: 2772268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion.
    Koop I; Fellgiebel A; Koop H; Schafmayer A; Arnold R
    Eur J Clin Invest; 1988 Oct; 18(5):517-23. PubMed ID: 3147905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.
    Koop I; Dorn S; Koop H; Witzleb S; Beglinger C; Schafmayer A; Arnold R
    Dig Dis Sci; 1991 Nov; 36(11):1625-32. PubMed ID: 1935502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maldigestion after total gastrectomy is associated with pancreatic insufficiency.
    Friess H; Böhm J; Müller MW; Glasbrenner B; Riepl RL; Malfertheiner P; Büchler MW
    Am J Gastroenterol; 1996 Feb; 91(2):341-7. PubMed ID: 8607504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
    Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
    Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meal-stimulated cholecystokinin release and exocrine pancreatic secretion in dogs.
    Hayakawa T; Katada N; Kondo T; Shibata T; Kodaira T; Ikei N; Hamaoka T
    Res Exp Med (Berl); 1988; 188(1):19-25. PubMed ID: 3353584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S; Li P; Chang TM; Chey WY
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy.
    Glasbrenner B; Dominguez-Munoz E; Riepl RL; Vetsi A; Malfertheiner P
    Dig Dis Sci; 1995 Feb; 40(2):406-11. PubMed ID: 7851207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.